February 6th 2024
Testosterone replacement therapy did not differ significantly from placebo in preventing diabetes progression in a substudy of the TRAVERSE randomized trial.
Tumor Growth Rate Doesn’t Predict Malignancy in AUS-A Thyroid Nodules
April 3rd 2019The American Thyroid Association guidelines recommend repeat fine-needle aspiration, molecular testing or diagnostic surgical resection if thyroid nodule size increases significantly, but a new study shows there is little evidence that significant tumor growth is a predictor of malignancy, especially in architectural atypia of undetermined significance (AUS-A) cases.